Apellis Pharmaceuticals, Inc. (APLS)
21.75
-0.25
(-1.14%)
USD |
NASDAQ |
Jan 23, 16:00
21.76
+0.01
(+0.05%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Assets (Annual): 885.05M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 785.03M |
| Alnylam Pharmaceuticals, Inc. | 4.302B |
| Ionis Pharmaceuticals, Inc. | 3.004B |
| Fortress Biotech, Inc. | 144.22M |
| Sarepta Therapeutics, Inc. | 3.963B |